Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapyFranz J. Hilke, Kerstin Clasen, Francesc Muyas et al.|Radiotherapy and Oncology|2020Cited by 57
Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophyJoohyun Park, John C. Ambrose, Arianna Tucci et al.|Genetics in Medicine|2022Cited by 20
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibitionChristopher Schroeder, Andrea Forschner, Sergios Gatidis et al.|Nature Communications|2024Cited by 19
Bi-allelic loss-of-function variants in BCAS3 cause a syndromic neurodevelopmental disorderHolger Hengel, Lüdger Schöls, Shabab B. Hannan et al.|The American Journal of Human Genetics|2021Cited by 17
Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophyJoohyun Park, Tobias B. Haack, Arianna Tucci et al.|Genetics in Medicine|2023Cited by 4